AnteoTech chief executive Derek Thomson.
The reusable test,which meets crucial health and safety conditions in Europe and in Britain,is expected to be used in mass testing programs such as concerts and sporting events.
The tests have not been approved for use in Australia.
AnteoTech chief executive Derek Thomson said he was “leverage opportunities that lie ahead of us”.
“CE Mark registration for the COVID-19 antigen rapid test platform provides AnteoTech with an opportunity to capture some of the large and growing European antigen rapid test market,” he said.
Premier Annastacia Palaszczuk said Queensland taxpayers spent $1.4 million to help AnteoTech progress the COVID-19 rapid test from prototype through to launch.
“Queensland is on the forefront of fighting the COVID pandemic globally,creating more jobs and economic opportunities locally,” Ms Palaszczuk said.
“Now AnteoTech is taking the pandemic fight to Europe.